Total Valuation
Champions Oncology has a market cap or net worth of €63.35M. The enterprise value is €99.48.
Market Cap€63.35M
Enterprise Value€99.48
Share Statistics
Champions Oncology has 13,893,569 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,893,569
Owned by Insiders14.81%
Owned by Institutions0.11%
Financial Efficiency
Champions Oncology’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -13.15%.
Return on Equity (ROE)-0.30
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-13.15%
Return on Capital Employed (ROCE)-0.16
Revenue Per Employee278.99K
Profits Per Employee-5.52K
Employee Count213
Asset Turnover2.20
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Champions Oncology is ―. Champions Oncology’s PEG ratio is 0.60.
PE Ratio―
PS Ratio1.39
PB Ratio20.93
Price to Fair Value20.93
Price to FCF-16.37
Price to Operating Cash Flow-16.58
PEG Ratio0.60
Income Statement
In the last 12 months, Champions Oncology had revenue of 59.42M and earned -1.18M in profits. Earnings per share was -0.08.
Revenue59.42M
Gross Profit28.52M
Operating Income-1.14M
Pretax Income-929.00K
Net Income-1.18M
EBITDA448.00K
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was -4.47M and capital expenditures -564.00K, giving a free cash flow of -5.04M billion.
Operating Cash Flow-4.47M
Free Cash Flow-5.04M
Free Cash Flow per Share-0.36
Dividends & Yields
Champions Oncology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.55
52-Week Price Change-11.62%
50-Day Moving Average5.08
200-Day Moving Average5.25
Relative Strength Index (RSI)51.73
Average Volume (3m)0.00
Important Dates
Champions Oncology upcoming earnings date is Sep 16, 2026, After Close (Confirmed).
Last Earnings DateJul 27, 2026
Next Earnings DateSep 16, 2026
Ex-Dividend Date―
Financial Position
Champions Oncology as a current ratio of 0.96, with Debt / Equity ratio of 116.73%
Current Ratio0.96
Quick Ratio0.96
Debt to Market Cap0.02
Net Debt to EBITDA-0.63
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Champions Oncology has paid 246.00K in taxes.
Income Tax246.00K
Effective Tax Rate-0.26
Enterprise Valuation
Champions Oncology EV to EBITDA ratio is 183.39, with an EV/FCF ratio of -16.31.
EV to Sales1.38
EV to EBITDA183.39
EV to Free Cash Flow-16.31
EV to Operating Cash Flow-18.37
Balance Sheet
Champions Oncology has €4.87M in cash and marketable securities with €4.60M in debt, giving a net cash position of €274.00K billion.
Cash & Marketable Securities€4.87M
Total Debt€4.60M
Net Cash€274.00K
Net Cash Per Share€0.02
Tangible Book Value Per Share€0.27
Margins
Gross margin is 48.00%, with operating margin of -1.92%, and net profit margin of -1.98%.
Gross Margin48.00%
Operating Margin-1.92%
Pretax Margin-1.56%
Net Profit Margin-1.98%
EBITDA Margin0.75%
EBIT Margin-1.56%
Analyst Forecast
The average price target for Champions Oncology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-3.54%
EPS Growth Forecast-121.14%